ARWR : Arrowhead Pharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-17 |
|---|---|---|---|---|
| 2023 | $23.31 | $22.74 | $23.95 | -4.08% |
| 2024 | $21.14 | $19.91 | $22.53 | -13.01% |
| 2025 | $18.04 | $16.07 | $19.69 | -25.76% |
| 2026 | $13.72 | $11.98 | $15.69 | -43.53% |
| 2027 | $10.7 | $9.97 | $11.72 | -55.99% |
| 2028 | $9.23 | $7.33 | $9.89 | -62.03% |
| 2029 | $6.26 | $5.98 | $6.82 | -74.22% |
| 2030 | $5.85 | $5.76 | $5.95 | -75.92% |
| 2031 | $5.72 | $5.7 | $5.75 | -76.45% |
| 2032 | $5.7 | $5.69 | $5.7 | -76.55% |
| 2033 | $5.69 | $5.69 | $5.69 | -76.58% |
The 20 Wall Street analysts offering Arrowhead Pharmaceuticals stock forecast in the last 6 months have average price target of
$58.5 with a high forecast of $90.0 and a low forecast of $31.0.
The average Arrowhead Pharmaceuticals stock forecast represents a 140.74%
increase from the last price of $24.2999992370605.
From AI system, total return is 2366.52% from 4098 forecasts.
For Arrowhead Pharmaceuticals stock forecast for 2023, 9 predictions are offered for each month of 2023 with average Arrowhead Pharmaceuticals stock
forecast of $23.31, a high forecast of $23.95, and a low forecast of $22.74.
The average Arrowhead Pharmaceuticals stock forecast 2023 represents a -4.08%
decrease from the last price of $24.2999992370605.
For Arrowhead Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Arrowhead Pharmaceuticals stock
forecast of $21.14, a high forecast of $22.53, and a low forecast of $19.91.
The average Arrowhead Pharmaceuticals stock forecast 2024 represents a -13.01%
decrease from the last price of $24.2999992370605.
For Arrowhead Pharmaceuticals stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Arrowhead Pharmaceuticals stock
forecast of $13.72, a high forecast of $15.69, and a low forecast of $11.98.
The average Arrowhead Pharmaceuticals stock forecast 2026 represents a -43.53%
decrease from the last price of $24.2999992370605.
For Arrowhead Pharmaceuticals stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Arrowhead Pharmaceuticals stock
forecast of $9.23, a high forecast of $9.89, and a low forecast of $7.33.
The average Arrowhead Pharmaceuticals stock forecast 2028 represents a -62.03%
decrease from the last price of $24.2999992370605.
For Arrowhead Pharmaceuticals stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Arrowhead Pharmaceuticals stock
forecast of $5.72, a high forecast of $5.75, and a low forecast of $5.7.
The average Arrowhead Pharmaceuticals stock forecast 2031 represents a -76.45%
decrease from the last price of $24.2999992370605.
For Arrowhead Pharmaceuticals stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average Arrowhead Pharmaceuticals stock
forecast of $5.69, a high forecast of $5.69, and a low forecast of $5.69.
The average Arrowhead Pharmaceuticals stock forecast 2033 represents a -76.58%
decrease from the last price of $24.2999992370605.
Please, see more forecasts below.
ARWR : Arrowhead Pharmaceuticals stock forecast by Wall Street Analysts
The average Arrowhead Pharmaceuticals stock forecast from last 6 month is $58.5, and this show a -11.06% decrease in average from the prior price target of the each prediction. Also, this average forecast of $58.5 represents a -11.54% decrease from the past average forecast of $66.13, 6 months ago from 8 wall street analysts.
Arrowhead Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-03-21 | $22.88 | -5.85% |
| 2023-03-22 | $21.12 | -7.68% |
| 2023-03-23 | $18.72 | -11.37% |
| 2023-03-24 | $17.33 | -7.44% |
| 2023-03-27 | $16.46 | -4.97% |
ARWR : Long term Arrowhead Pharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $23.95 , for 2024 Mar. is $22.07 , for 2027 Mar. is $11.25 , for 2028 Mar. is $9.75 , for 2032 Mar. is $5.70 , and for 2033 Mar. is $5.69.
ARWR : Arrowhead Pharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $23.95 | -1.46% |
| 2023 May. | $23.67 | -1.13% |
| 2023 Jun. | $23.53 | -0.62% |
| 2023 Jul. | $23.45 | -0.35% |
| 2023 Aug. | $23.35 | -0.43% |
| 2023 Sep. | $23.21 | -0.58% |
| 2023 Oct. | $23.00 | -0.92% |
| 2023 Nov. | $22.88 | -0.50% |
| 2023 Dec. | $22.74 | -0.63% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $22.53 | -0.94% |
| 2024 Feb. | $22.31 | -0.97% |
| 2024 Mar. | $22.07 | -1.07% |
| 2024 Apr. | $21.73 | -1.52% |
| 2024 May. | $21.42 | -1.46% |
| 2024 Jun. | $21.13 | -1.36% |
| 2024 Jul. | $20.93 | -0.93% |
| 2024 Aug. | $20.74 | -0.92% |
| 2024 Sep. | $20.51 | -1.08% |
| 2024 Oct. | $20.29 | -1.07% |
| 2024 Nov. | $20.10 | -0.97% |
| 2024 Dec. | $19.91 | -0.92% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $19.69 | -1.10% |
| 2025 Feb. | $19.41 | -1.42% |
| 2025 Mar. | $19.13 | -1.45% |
| 2025 Apr. | $18.88 | -1.30% |
| 2025 May. | $18.63 | -1.35% |
| 2025 Jun. | $18.34 | -1.57% |
| 2025 Jul. | $18.01 | -1.77% |
| 2025 Aug. | $17.66 | -1.98% |
| 2025 Sep. | $17.28 | -2.11% |
| 2025 Oct. | $16.89 | -2.27% |
| 2025 Nov. | $16.48 | -2.40% |
| 2025 Dec. | $16.07 | -2.50% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $15.69 | -2.39% |
| 2026 Feb. | $15.30 | -2.47% |
| 2026 Mar. | $14.91 | -2.52% |
| 2026 Apr. | $14.54 | -2.51% |
| 2026 May. | $14.18 | -2.47% |
| 2026 Jun. | $13.83 | -2.48% |
| 2026 Jul. | $13.49 | -2.45% |
| 2026 Aug. | $13.16 | -2.48% |
| 2026 Sep. | $12.84 | -2.42% |
| 2026 Oct. | $12.52 | -2.45% |
| 2026 Nov. | $12.24 | -2.29% |
| 2026 Dec. | $11.98 | -2.07% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $11.72 | -2.19% |
| 2027 Feb. | $11.47 | -2.09% |
| 2027 Mar. | $11.25 | -1.98% |
| 2027 Apr. | $11.04 | -1.86% |
| 2027 May. | $10.85 | -1.72% |
| 2027 Jun. | $10.68 | -1.58% |
| 2027 Jul. | $10.52 | -1.45% |
| 2027 Aug. | $10.38 | -1.31% |
| 2027 Sep. | $10.26 | -1.18% |
| 2027 Oct. | $10.15 | -1.06% |
| 2027 Nov. | $10.05 | -0.96% |
| 2027 Dec. | $9.97 | -0.87% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $9.89 | -0.79% |
| 2028 Feb. | $9.82 | -0.73% |
| 2028 Mar. | $9.75 | -0.68% |
| 2028 Apr. | $9.69 | -0.66% |
| 2028 May. | $9.62 | -0.66% |
| 2028 Jun. | $9.55 | -0.72% |
| 2028 Jul. | $9.47 | -0.86% |
| 2028 Aug. | $9.36 | -1.16% |
| 2028 Sep. | $9.19 | -1.86% |
| 2028 Oct. | $8.86 | -3.56% |
| 2028 Nov. | $8.21 | -7.34% |
| 2028 Dec. | $7.33 | -10.72% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $6.82 | -6.91% |
| 2029 Feb. | $6.59 | -3.44% |
| 2029 Mar. | $6.46 | -2.01% |
| 2029 Apr. | $6.36 | -1.41% |
| 2029 May. | $6.29 | -1.13% |
| 2029 Jun. | $6.23 | -0.97% |
| 2029 Jul. | $6.18 | -0.87% |
| 2029 Aug. | $6.13 | -0.79% |
| 2029 Sep. | $6.08 | -0.73% |
| 2029 Oct. | $6.04 | -0.67% |
| 2029 Nov. | $6.01 | -0.60% |
| 2029 Dec. | $5.98 | -0.50% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $5.95 | -0.38% |
| 2030 Feb. | $5.93 | -0.34% |
| 2030 Mar. | $5.91 | -0.34% |
| 2030 Apr. | $5.89 | -0.34% |
| 2030 May. | $5.88 | -0.33% |
| 2030 Jun. | $5.86 | -0.33% |
| 2030 Jul. | $5.84 | -0.31% |
| 2030 Aug. | $5.82 | -0.30% |
| 2030 Sep. | $5.80 | -0.28% |
| 2030 Oct. | $5.79 | -0.26% |
| 2030 Nov. | $5.78 | -0.23% |
| 2030 Dec. | $5.76 | -0.21% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $5.75 | -0.18% |
| 2031 Feb. | $5.74 | -0.16% |
| 2031 Mar. | $5.74 | -0.14% |
| 2031 Apr. | $5.73 | -0.12% |
| 2031 May. | $5.72 | -0.10% |
| 2031 Jun. | $5.72 | -0.08% |
| 2031 Jul. | $5.72 | -0.07% |
| 2031 Aug. | $5.71 | -0.05% |
| 2031 Sep. | $5.71 | -0.04% |
| 2031 Oct. | $5.71 | -0.04% |
| 2031 Nov. | $5.71 | -0.03% |
| 2031 Dec. | $5.70 | -0.03% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $5.70 | -0.02% |
| 2032 Feb. | $5.70 | -0.02% |
| 2032 Mar. | $5.70 | -0.02% |
| 2032 Apr. | $5.70 | -0.02% |
| 2032 May. | $5.70 | -0.02% |
| 2032 Jun. | $5.70 | -0.02% |
| 2032 Jul. | $5.70 | -0.01% |
| 2032 Aug. | $5.70 | -0.01% |
| 2032 Sep. | $5.70 | -0.01% |
| 2032 Oct. | $5.69 | -0.01% |
| 2032 Nov. | $5.69 | -0.01% |
| 2032 Dec. | $5.69 | -0.01% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $5.69 | -0.01% |
| 2033 Feb. | $5.69 | -0.01% |
| 2033 Mar. | $5.69 | -0.01% |
Frequently Asked Questions about Arrowhead Pharmaceuticals stock forecast
Is Arrowhead Pharmaceuticals a good long term stock?
From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to Tudal, the Arrowhead Pharmaceuticals stock price forecast for 2023 Apr. is $23.9457482006944 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to Tudal, the Arrowhead Pharmaceuticals stock price forecast for 2024 Mar. is $22.0683304861353 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to Tudal, the Arrowhead Pharmaceuticals stock price forecast for 2027 Mar. is $11.2466933763809 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to Tudal, the Arrowhead Pharmaceuticals stock price forecast for 2028 Mar. is $9.74947910588518 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to Tudal, the Arrowhead Pharmaceuticals stock price forecast for 2032 Mar. is $5.70050408238866 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to Tudal, the Arrowhead Pharmaceuticals stock price forecast for 2033 Mar. is $5.69099849281305
Is Arrowhead Pharmaceuticals stock overvalued?
Arrowhead Pharmaceuticals (ARWR) stock is expected to go DOWN . Therefore, Tudal would say that Arrowhead Pharmaceuticals (ARWR) stock is overvalued.
Will Arrowhead Pharmaceuticals stock price go up?
No. The Arrowhead Pharmaceuticals stock price forecast for 2024 Mar. is $22.0683304861353
Is Arrowhead Pharmaceuticals stock a good buy now?
Since closing price on 2023-03-17 is $24.2999992370605 and forecast for 2024 Mar. is $22.07, Arrowhead Pharmaceuticals stock is not a good 1 year investment.